In August, the Endocrine Society launched its first global outreach campaign, EndoCares: Diabetes, in Lima, Peru.
This two-day program — achieved through strategic partnerships with three local organizations: Sociedad Peruana de Endocrinologia, Asociacion de Diabetes del Peru, and Liga Peruana de Lucha Contra la Diabetes — included a session to educate healthcare providers on diabetes care, a one-day congress for patients with type 2 diabetes, and a one-day type 1 diabetes-focused workshop for patients with type 1 diabetes.
Society members Agustin Busta, MD, Lisa Fish, MD, and Guillermo Umpierrez, MD, led the provider-focused session during the Peruvian Society for Endocrinology’s Annual Meeting on Saturday August 6. On Sunday, the two simultaneous one-day, patient-focused sessions took place. Together, EndoCares: Diabetes was able to reach 1,012 healthcare providers, 500 patients with T2DM, 100 patients with T1DM, and key government officials in charge of healthcare policy.
Fish and other experts engaged with healthcare providers in the community and educated them on the latest advancements in diabetes care. Patients and their families who attended the EndoCares events learned about the rights of patients, how to make the most of their appointment with their healthcare provider, and how to develop effective teamwork with their caregiver.
EndoCares also had an unexpected, but welcomed, benefit: more than quadrupling the number of Endocrine Society members in Peru. Through on-site membership processing, the Society gained 133 new members, an all-time record that increased the Society’s Peruvian membership from 37 to 170.
EndoCares was developed to provide medical resources, coaching, and education to patients suffering from endocrine-related conditions in underserved areas of the world. In addition, EndoCares aims to foster the next generation of endocrinologists and healthcare providers by creating opportunities to further their education and professional network.
A more in-depth feature about the program is scheduled for the November Endocrine News, an issue devoted to Diabetes Awareness Month.